FUSCO, FERDINANDO
 Distribuzione geografica
Continente #
NA - Nord America 1.999
EU - Europa 1.511
AS - Asia 472
AF - Africa 22
SA - Sud America 15
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 4.021
Nazione #
US - Stati Uniti d'America 1.925
IT - Italia 749
CN - Cina 399
NL - Olanda 173
FI - Finlandia 171
UA - Ucraina 119
IE - Irlanda 76
CA - Canada 72
DE - Germania 72
SE - Svezia 57
GB - Regno Unito 39
VN - Vietnam 24
FR - Francia 22
CI - Costa d'Avorio 21
IR - Iran 10
BR - Brasile 9
IN - India 9
CH - Svizzera 7
SG - Singapore 6
HK - Hong Kong 5
JP - Giappone 5
BE - Belgio 4
RO - Romania 4
TH - Thailandia 4
TR - Turchia 4
AL - Albania 3
AR - Argentina 3
ES - Italia 3
DK - Danimarca 2
HU - Ungheria 2
ID - Indonesia 2
KR - Corea 2
RS - Serbia 2
AU - Australia 1
CL - Cile 1
CO - Colombia 1
EU - Europa 1
GR - Grecia 1
HN - Honduras 1
KZ - Kazakistan 1
MC - Monaco 1
MK - Macedonia 1
MX - Messico 1
NG - Nigeria 1
PH - Filippine 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
VE - Venezuela 1
Totale 4.021
Città #
Chandler 308
Millbury 209
Princeton 178
Amsterdam 162
Nanjing 139
Naples 115
Napoli 113
Boston 102
Beijing 80
Ashburn 77
Ottawa 61
Wilmington 59
Jacksonville 51
Nanchang 40
Des Moines 39
Augusta 35
Shenyang 34
Norwalk 32
Hebei 30
Dong Ket 24
Falls Church 23
Ann Arbor 22
Frankfurt am Main 21
Milan 21
Tianjin 19
Jiaxing 16
Seattle 15
Lawrence 13
Rome 13
Changsha 12
Redwood City 12
Cambridge 11
Bologna 10
Toronto 10
Zola Predosa 10
Washington 8
Eindhoven 7
Kronberg 7
Kunming 7
Los Angeles 7
Redmond 7
San Mateo 7
Ardabil 6
Benevento 6
Dublin 6
Houston 6
Boardman 5
Cerro Maggiore 5
Salt Lake City 5
Berlin 4
Hong Kong 4
Lanzhou 4
Orange 4
Shanghai 4
Southwark 4
Abbasanta 3
Bangkok 3
Bari 3
Castellammare Di Stabia 3
Cazzago San Martino 3
Formia 3
Gent 3
Hangzhou 3
Leawood 3
Montoro 3
Nürnberg 3
Palermo 3
Pisa 3
Poggiomarino 3
Pozzuoli 3
Teverola 3
Tirana 3
Torre Annunziata 3
Torre Del Greco 3
Udine 3
Acerra 2
Acquafredda 2
Altindag 2
Avellino 2
Caserta 2
Castellammare di Stabia 2
Cellio 2
Cercola 2
Copenhagen 2
Cusano Milanino 2
Dearborn 2
Florence 2
Genova 2
Grado 2
Guangzhou 2
Jakarta 2
Jinan 2
London 2
Lucera 2
Milazzo 2
Mountain View 2
Palma Campania 2
Pitesti 2
Polignano A Mare 2
San Salvo 2
Totale 2.339
Nome #
Colonvaginoplastica versus ileovaginoplastica nel transessualismo andro-ginoide: studio di confronto.” 173
CISTECTOMIA RADICALE CON NEOVESCICA ORTOTOPICA IN PAZIENTI CON LAVARIANTE NESTED DEL CARCINOMA UROTELIALE: NOSTRA ESPERIENZA CLINICACON FOLLOW-UP DI 36 MESI. 148
Perceptions, Expectations, Preferences, and Attitudes Toward Premature Ejaculation, Its Diagnosis and Topical Treatment with Fortacin™ Spray: Results from an Expert Panel Discussion 91
Vaginoplastica con flap penoscrotale nel transessualismo andro-ginoide 86
Correlation between detrusor collagen content and urinary symptoms in patients with prostatic obstruction 59
Urothelium muscarinic activation phosphorylates CBS Ser227 via cGMP/PKG pathway causing human bladder relaxation through H 2 S production 59
SPHINGOSINE-1PHOSPHATE INDUCES ENDOTHELIAL NOS ACTIVATION THROUGH PHOSPHORYLATION IN HUMAN CORPUS CAVERNOSUM 53
LA DISFUNZIONE ERETTILE (DE) NEL PAZIENTE EMODIALIZZATO PRIMA EDOPO IL TRAPIANTO RENALE 50
Erectile dysfunction after surgical treatment. 49
Donor and Recipient Outcomes following Robotic-Assisted Laparoscopic Living Donor Nephrectomy: A Systematic Review 46
A report from a single institute's 14-year experience in treatment of male-to-female transsexuals. 45
VAGINOPLASTICA CON FLAP PENOSCROTALE NEL TRANSESSUALISMO ANDRO-GINOIDE 45
A new biopsy technique to investigate Peyronie's disease associated histologic alterations: results with two different forms of therapy. 43
Biparametric 3T Magentic Resonance Imaging for prostatic cancer detection in a biopsy-naïve patient population: a further improvement of PI-RADS v2? 42
"A new validated questionnaire in the clinical evaluation of female sexual dysfunction (FSDQ): an Italian proposal" 40
Demographic and comorbidity profile of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a real-life clinical setting: Are 5-alpha-reductase inhibitor consumers different? 40
Complications and quality of life in elderly patients with several comorbidities undergoing cutaneous ureterostomy with single stoma or ileal conduit after radical cystectomy 40
The Role of the Hydrogen Sulfide Pathway in Male and Female Urogenital System in Health and Disease 40
Efficacy and safety of ciprofloxacin XR 1000 mg once daily versus ciprofloxacin 500 mg twice daily in the treatment of complicated urinary tract infections 39
Nuova tecnica di biopsia di placca nella malattia di La Peyronie 39
Diagnostic accuracy of three tesla biparametric magnetic resonance imaging of the prostate, prostate specific antigen density and their combination for the detection of clinically significant prostate cancer: Results from a retrospective study 39
BPH/LUTS and ED: Common Pharmacological Pathways for a Common Treatment 38
Colonvaginoplastica versus ileovaginoplastica 37
A new era in the treatment of erectile dysfunction: chronic phosphodiesterase type 5 inhibition 37
Detection of Extraprostatic Extension of Cancer on Biparametric MRI Combining Texture Analysis and Machine Learning: Preliminary Results 37
Clinical Efficacy of Silodosin in Patients with Severe Lower Urinary Tract Symptoms Related to Benign Prostatic Obstruction: A Pooled Analysis of Phase 3 and 4 Trials 37
Human Cystathionine-β-Synthase Phosphorylation on Serine227 Modulates Hydrogen Sulfide Production in Human Urothelium 36
A new biopsy technique to investigate Peyronie's disease associated histologic alterations: results with two different forms of therapy. 34
CASO DI DUPLICAZIONE URETERALE INCOMPLETA CON MEGAURETERE ASSOCIATOA DISTRETTO SUPERIORE ESCLUSO E DISTRETTO INFERIORE PERFETTAMENTEFUNZIONANTE 34
Androgens and benign prostatic hyperplasia 34
La standardizzazione della cavernosometria nella valutazione delle fughe venose. 34
UROTENSIN II AS A POSSIBLE SERUM MARKER OF ERECTILE DYSFUNCTION 34
Prevalence and risk factors of erectile dysfunction in patients with hepatitis B virus or hepatitis C virus or chronic liver disease: Results from a prospective study 34
Does physical activity regulate prostate carcinogenesis and prostate cancer outcomes? A narrative review 34
Sildenafil effect on the human bladder involves the L-cysteine/hydrogen sulfide pathway: a novel mechanism of action of phosphodiesterase type 5 inhibitors 33
Hyperbaric Oxygen Therapy reduces mortality in patients with Fournier's gangrene. Results from a multi-institutional observational study 32
A case of highly aggressive anaplastic seminoma of the testis presenting as fungating scrotal lesion 32
Detrusor overactivity and underactivity: implication for lower urinary tract symptoms related to benign prostate hyperplasia diagnosis and treatment 31
A new era in the treatment of erectile dysfunction: chronic phosphodiesterase type 5 inhibition. 31
Analisi di immagine computerizzata del corpo cavernoso post prostatectomia radicale: Basi ultrastrutturali del deficit erettile 31
A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease. 28
Androgens and morphologic remodeling at penile and cardiovascular levels: a common piece in complicated puzzles? 28
A new biopsy technique to investigate Peyronie's disease associated histologic alterations: results with two different forms of therapy. 28
A new biopsy technique to investigate Peyronie's disease associated histologic alterations: Results with two different forms of therapy 28
Evaluation of an alternative dosing regimen with tadalafil, three times per week, for men with erectile dysfunction: SURE study in Italy. 27
An ex vivo standardized assay to measure human platelet cGMP 27
A First Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial Evaluating Extracorporeal Shock Wave Therapy for the Treatment of Peyronie's Disease 27
Endogenous urotensin II selectively modulates erectile function through eNOS 26
“A new valitated questionnarie in the clinical evaluation of female sexual dysfunction. An Italian Proposal” 26
Attività miorilassante periferica della apomorfina e di un agonista selettivo del recettore D1 sul tessuto cavernoso umano 26
Alpha-1 adrenergic antagonists, 5-alpha reductase inhibitors, phosphodiesterase type 5 inhibitors, and phytotherapic compounds in men with lower urinary tract symptoms suggestive of benign prostatic obstruction: A systematic review and meta-analysis of ur 26
Silodosin 8 mg improves benign prostatic obstruction in Caucasian patients with lower urinary tract symptoms suggestive of benign prostatic enlargement: results from an explorative clinical study 24
Invovement of beta-3-adrenergic receptor activation via Cyclic GMP-but not No-dependent mechanism in human corpus cavernosum function. 23
Determinants of Erectile Dysfunction Risk in a Large Series of Italian Men Attending Andrology Clinics 23
Ejaculatory abstinence influences intravaginal ejaculatory latency time: Results from a prospective randomized trial 23
A standardized procedure for using human corpus cavernosum stripa to evaluate drug activity and the role of mediators in Erectile Dysfunctions 23
Involvement of L-cysteine/H2S pathway in human bladder homeostasis 23
Female sexual dysfunction: an update on physiopathology. 22
Neurophysiologic evaluation of central-peripheral sensory and motor pudendal pathways in primary premature ejaculation. 22
Platelet Cyclic Guanosine Monophosphate as a Biomarker of Phosphodiesterase Type 5 Inhibitor Efficacy in the Treatment of Erectile Dysfunction: A Randomized Placebo-Controlled Study 22
QUALITà DELLA VITA SESSUALE E SODDISFAZIONE DEL PAZIENTE DOPO CHIRURGIA PENIS-SPARING PER LESIONI PENIENE BENIGNE, PREMALIGNE O MALIGNE 22
Sildenafil Effect on the Human Bladder Involves the L-cysteine/Hydrogen Sulfide Pathway: A Novel Mechanism of Action of Phosphodiesterase Type 5 Inhibitors 22
Benign Prostatic Obstruction Relief in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Enlargement Undergoing Endoscopic Surgical Procedures or Therapy with Alpha-Blockers: A Review of Urodynamic Studies 22
Endoscopic Spatulation of the Intramural Ureter: A Technique to Prevent Stenosis of the Ureterovesical Junction in Patients Undergoing Resection of the Ureteral Orifice 22
Health-related quality of life in bladder cancer patients undergoing radical cystectomy and urinary stoma: Still many gaps 22
Did men with erectile dysfunction discuss their condition with partner and physicians? A survey of men attending a free call information service. 21
Involvement of beta 3-adrenergic receptor activation via cyclic GMP- but not NO-dependent mechanisms in human corpus cavernosum function. 21
Female sexual dysfunction: an update on physiopathology. 21
ERYTHEMATOUS ERUPTION WITH LINEAR VESCICULATION AND EOSINOPHILIA AT BIRTH 21
Pharmaco-prothesis:How,when and why? Injection technique 21
Androgens and benign prostatic hyperplasia 21
Female sexual dysfunction: an update on physiopathology. 21
Endogenous urotensin–II induced-penile erection trhough eNOS phosphorylation in human corpus cavernosum 21
Tamsulosin plus a new complementary and alternative medicine in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: Results from a retrospective comparative study 21
Efficacy and safety of ciprofloxacin XR 1000 mg once daily versus ciprofloxacin 500 mg twice daily in the treatment of complicated urinary tract infections. 20
PROSTATECTOMIA RADICALE PERINEALE VS PROSTATECTOMIA RADICALERETROPUBICA IN PAZIENTI PRECEDENTEMENTE SOTTOPOSTI A CHIRURGIAPROSTATICA: RISULTATI CHIRURGICI E FUNZIONALI 20
L'ANALISI DI UN TISSUE MICROARRAY RIVELA UNA SIGNIFICATIVA ASSOCIAZIONE TRA NEUROD1 ECROMOGRANINA NELLE NEOPLASIE PROSTATICHE 20
Induratio penis plastica: nostra esperienza nell’associazione della terapia fisica alla medica. 20
Colonvaginoplastica versus ileovaginoplastica nel transessualismo andro ginoide: studio di confronto 20
Female sexual dysfunction: an update on physiopathology. ( Review ) 20
“A new procedure for penile biopsy” 20
Erectile dysfunction in patients with chronic viral hepatitis: a systematic review of the literature 20
Dapoxetine treatment in patients with lifelong premature ejaculation: The reasons of a "waterloo" 20
Incidentally discovered pelvic paraganglioma: A case report 20
α1-Blockers Improve Benign Prostatic Obstruction in Men with Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis of Urodynamic Studies 19
Transperineal repair of a persistent rectourethral fistula using aporcine dermal graft 19
Erectile dysfunction after surgical treatment. 18
the detrusor muscle: an innocent victim of bladder outlet obstruction 18
Phase Ii Multicentric Study of Sunitinib In Metastatic Renal Cell Carcinoma (mrcc) With A Poor Prognosis Refractory To Immunotherapy 18
Neurophysiologic evaluation of central-peripheral sensory and motor pudendal pathways in primary premature ejaculation 18
Hydrogen sulfide as a mediator of human corpus cavernosum smooth-muscle relaxation 17
Periprostatic nerve block (PNB) alone vs PNB combined with an anaesthetic-myorelaxant agent cream for prostate biopsy: a prospective, randomized double-arm study. 17
STUDIO PROSPETTICO RANDOMIZZATO, DOPPIO CIECO, PLACEBO CONTROLLATO VOLTO A VALUTAREL’EFFICACIA DELL ESWT NEL TRATTAMENTO DELLA MALATTIA DI LA PEYRONIE 17
L'IDROGENO SOLFORATO COME NUOVO MEDIATORE DELL'EREZIONE PENIENA NELL'UOMO 17
EFFICACY AND SAFETY OF CIPROFLOXACIN XR 1000 MG ONCE DAILY VERSUS CIPROFLOXACIN 500 MG TWICE DAILY IN THE TREATMENT OF COMPLICATED URINARY TRACT INFECTIONS 17
Progressive bladder remodeling due to bladder outlet obstruction: a systematic review of morphological and molecular evidences in humans 17
Renal Transplantation Does Not Improve Erectile Function in Hemodialysed Patients. 16
LA DISFUNZIONE ERETTILE (DE) NEL PAZIENTE EMODIALIZZATO PRIMA E DOPO IL TRAPIANTO RENALE 16
URETROCISTOPROSTATECTOMIA CON DOPPIO ACCESSO ADDOMINO-PERINEALE: VARIANTE DITECNICA 16
STUDIO PROSPETTICO RANDOMIZZATO, DOPPIO CIECO, PLACEBO CONTROLLATOVOLTO A VALUTARE L’EFFICACIA DELL’ ESWT NEL TRATTAMENTO DELLAMALATTIA DI LA PEYRONIE 16
Totale 3.193
Categoria #
all - tutte 18.757
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.757


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201924 0 0 0 0 0 0 0 0 0 0 10 14
2019/2020544 280 7 22 3 28 4 12 14 7 49 82 36
2020/2021466 27 18 37 24 41 72 27 23 40 18 101 38
2021/2022966 20 7 15 10 6 19 12 34 88 154 131 470
2022/2023941 206 58 16 63 97 80 6 75 119 171 39 11
2023/2024482 26 78 160 34 44 43 16 52 7 20 2 0
Totale 4.293